Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Acadia Pharmaceuticals Inc. (ACAD)

Pharmaceutical Preparations

https://www.acadia-pharm.com

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

12830 EL CAMINO REAL, SUITE 400
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/27/2004

Market Cap

2,562,784,200

Shares Outstanding

164,180,000

Weighted SO

164,180,377

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

MDGL --.--%

VKTX --.--%

SRPT --.--%

HEPA --.--%

PTCT --.--%

RVPH --.--%

ATHA --.--%

FBIO --.--%

CABA --.--%

Beta

0.3800

Last Div

0.0000

Range

14.55-32.59

Chg

0.0500

Avg Vol

1846241

Mkt Cap

2562784200

Exch

NASDAQ

Country

US

Phone

858 558 2871

DCF Diff

2.8529

DCF

15.7171

Div Yield

0.0000

P/S

2.8778

EV Multiple

75.0609

P/FV

4.9502

Div Yield %

0.0000

P/E

83.6827

PEG

3.8405

Payout

0.0000

Current Ratio

2.1575

Quick Ratio

1.9458

Cash Ratio

0.5243

DSO

45.2464

DIO

354.2571

Op Cycle

399.5035

DPO

98.4738

CCC

301.0297

Gross Margin

0.9172

Op Margin

0.0256

Pretax Margin

0.0514

Net Margin

0.0343

Eff Tax Rate

0.3318

ROA

0.0334

ROE

0.0689

ROCE

0.0396

NI/EBT

0.6682

EBT/EBIT

2.0050

EBIT/Rev

0.0256

Debt Ratio

0.0631

D/E

0.1116

LT Debt/Cap

0.0837

Total Debt/Cap

0.1004

Int Coverage

0.0000

CF/Debt

1.3967

Equity Multi

1.7691

Rec Turnover

8.0669

Pay Turnover

3.7066

Inv Turnover

1.0303

FA Turnover

15.7522

Asset Turnover

0.9742

OCF/Share

0.4864

FCF/Share

0.4861

Cash/Share

3.0259

OCF/Sales

0.0904

FCF/OCF

0.9994

CF Coverage

1.3967

ST Coverage

7.6911

CapEx Coverage

1610.5200

Div&CapEx Cov

1610.5200

P/BV

4.9502

P/B

4.9502

P/S

2.8778

P/E

83.6827

P/FCF

31.8453

P/OCF

31.7632

P/CF

31.7632

PEG

3.8405

P/S

2.8778

EV Multiple

75.0609

P/FV

4.9502

DPS

0.0000

Latest Headlines (EST)

Zacks Investment Research Jan 15, 13:42 Adicet (ACET) Stock Rallies 130% in a Month: Here's Why Zacks Investment Research Jan 15, 13:42 Adicet (ACET) Stock Rallies 130% in a Month: Here's Why Zacks Investment Research Jan 15, 13:42 Adicet (ACET) Stock Rallies 130% in a Month: Here's Why Zacks Investment Research Dec 29, 12:51 Acadia's (ACAD) Nuplazid Sales Drive Growth Amid Competition Benzinga Dec 29, 09:20 Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday Zacks Investment Research Nov 24, 12:29 Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why

Revenue Product Segmentation